Airfinity provides global health intelligence and analytics that decision makers can trust, understand and act upon to save lives.
Cited over 20,000 times in 2021 as a pioneer in predictive intelligence.
the-economist.png
nikkei.png
the-bmj.png
bloomberg.png
cnn.png
nature.png
financial-times.png

Analysis & Insights

Global Supply and Demand: The future of the antivirals landscape

Lead Analyst and Head of Therapeutics, Dr Arsalan Azad, hosts an exclusive session on antiviral supply and demand, sharing Airfinity’s independent analysis and forecasts on the treatment landscape.


More from Airfinity

What does Monkeypox teach us about pandemic preparedness?Key factors hindering global oral antiviral uptakeAirfinity’s Q1 COVID-19 vaccine revenue forecast more accurate than market consensusAirfinity live on stage at FT US Pharma and Biotech Summit 2022Global sales estimate for COVID-19 antiviral pills increased by 60% to $32.5bnThe AAV Gene Therapy Regulatory LandscapeView All →

In the News

Is monkeypox an international public-health emergency?

The Economist

UK prepares to include over-50s in autumn Covid booster campaign

Financial Times

WHO to share vaccines to stop monkeypox amid inequity fears

Associated Press

Waiving intellectual property rights is a flawed solution to achieving Covid-19 vaccine equity

STAT

Airfinity live on stage at FT US Pharma and Biotech Summit 2022

FT Live

View All →

A pioneer in predictive health intelligence

Understand

What's happening in a given disease area?

Airfinity is the most comprehensive, single source of intelligence for new developments in your chosen area.

Predict

Identify the potential of a drug or vaccine candidate.

Our suite of dynamic predictive indicators help you navigate highly dynamic and uncertain market developments and see the real opportunities.

Act

Helping you decide which candidate to invest in.

All information that impacts the future of a therapy is collected, structured and analysed in near real time and provides you with probabilistic tools to inform the big decision.

The world’s most comprehensive infectious disease platform.

Airfinity combines proprietary surveillance tools and forecast models with expert analysis for dozens of infectious diseases, including COVID-19, Influenza and RSV.

OUR PLATFORM:

New science
Market & Production
Policies
Disease & Prevalence
Learn More →

What our users say?

who

“The Airfinity report is a guide for world leaders to fix a more ambitious action plan.”

Gordon Brown, WHO Ambassador for Global Health Financing & former UK Prime Minister

hm government

“Airfinity has been instrumental in our country's COVID response.”

Head of UK Government
Vaccine Task Force

ifpma

“Vaccine production data from Airfinity has been spot on. In a fast moving pandemic, these forecasts are really important for evidence-based policy making.”

Director General,
IFPMA

the economist

“Airfinity has been critical in furnishing us and the rest of the world with COVID-19 numbers.”

James Fransham, Data Journalist,
The Economist